Contact this trialFirst, we need to learn more about you.
Immunotherapy
Combination Therapy for Solid Tumors
Recruiting1 awardPhase 1
Oklahoma City, Oklahoma
This trial is testing two new drugs, AN2025 and AN0025, alone and with an existing cancer drug, Atezolizumab, in patients with advanced or spreading tumors. The goal is to see if these new drugs can help fight cancer better, either by themselves or by enhancing the effects of Atezolizumab.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service